243 related articles for article (PubMed ID: 11028812)
1. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study.
Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T
J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812
[TBL] [Abstract][Full Text] [Related]
2. Expression of VCAM-1, ICAM-1, E-selectin, and P-selectin on endothelium in situ in patients with erythroderma, mycosis fungoides and atopic dermatitis.
Sigurdsson V; de Vries IJ; Toonstra J; Bihari IC; Thepen T; Bruijnzeel-Koomen CA; van Vloten WA
J Cutan Pathol; 2000 Oct; 27(9):436-40. PubMed ID: 11028813
[TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
[TBL] [Abstract][Full Text] [Related]
4. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
Sentis HJ; Willemze R; Scheffer E
J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
[TBL] [Abstract][Full Text] [Related]
5. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
6. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
7. Sézary cell count in exfoliative dermatitis.
Duangurai K; Piamphongsant T; Himmungnan T
Int J Dermatol; 1988 May; 27(4):248-52. PubMed ID: 2968960
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions.
Doherty SD; Ni X; Doherty CB; Jones D; Zhao X; Owen LB; Duvic M
Arch Dermatol Res; 2006 Dec; 298(7):353-6. PubMed ID: 17021762
[TBL] [Abstract][Full Text] [Related]
9. A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.
Luherne C; Menguy S; Ferte T; Beylot-Barry M; Seneschal J; Milpied B; Vial JP; Gros A; Amintas S; Vergier B; Pham-Ledard A
Acta Derm Venereol; 2022 Sep; 102():adv00773. PubMed ID: 35758515
[TBL] [Abstract][Full Text] [Related]
10. Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sézary cell line by interferon-gamma.
Dummer R; Sigg-Zemann S; Kalthof K; Muletta S; Meyer JC; Burg G
Dermatology; 1994; 189(2):120-4. PubMed ID: 7915555
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic erythroderma: a follow-up study of 28 patients.
Sigurdsson V; Toonstra J; van Vloten WA
Dermatology; 1997; 194(2):98-101. PubMed ID: 9094454
[TBL] [Abstract][Full Text] [Related]
12. Biopsy correlation of surface area vs. single-axis measurements on computed tomography scan of lymph nodes in patients with erythrodermic mycosis fungoides and Sézary syndrome.
Haththotuwa R; Zilinskiene L; Oliff J; Vydianath B; Amel-Kashipaz R; Stevens A; Shah F; Chaganti S; Scarisbrick J
Br J Dermatol; 2017 Sep; 177(3):877-878. PubMed ID: 28012157
[No Abstract] [Full Text] [Related]
13. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA.
Asadullah K; Döcke WD; Haeussler A; Sterry W; Volk HD
J Invest Dermatol; 1996 Dec; 107(6):833-7. PubMed ID: 8941670
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies.
Ram-Wolff C; Martin-Garcia N; Bensussan A; Bagot M; Ortonne N
Am J Dermatopathol; 2010 Dec; 32(8):755-63. PubMed ID: 20559121
[TBL] [Abstract][Full Text] [Related]
15. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
16. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.
Mangold AR; Thompson AK; Davis MD; Saulite I; Cozzio A; Guenova E; Hodak E; Amitay-Laish I; Pujol RM; Pittelkow MR; Gniadecki R
J Am Acad Dermatol; 2017 Oct; 77(4):719-727. PubMed ID: 28709694
[TBL] [Abstract][Full Text] [Related]
17. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).
Cirée A; Michel L; Camilleri-Bröet S; Jean Louis F; Oster M; Flageul B; Senet P; Fossiez F; Fridman WH; Bachelez H; Tartour E
Int J Cancer; 2004 Oct; 112(1):113-20. PubMed ID: 15305382
[TBL] [Abstract][Full Text] [Related]
18. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
[TBL] [Abstract][Full Text] [Related]
19. Interstitial granuloma after interferon-gamma and narrowband UVB therapy in a patient with mycosis fungoides: Immunological and histopathological considerations.
Goto H; Sugita K; Yamamoto O
J Cutan Pathol; 2021 May; 48(5):689-693. PubMed ID: 33442885
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of a subpopulation of Ia+ T-helper cells in mycosis fungoides and the Sézary syndrome.
Hofman FM; Meyer PR; Yanagihara E; Modlin RL; Rea TH; Parker JW; Lukes RJ; Taylor CR
Am J Dermatopathol; 1983 Apr; 5(2):135-43. PubMed ID: 6224436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
